Viewing nowCombinationAvaltan Tablet 5/80 Milligrams
Valsartan 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 201402488 · Approved 2014.05.30 · Insurance code 657306460
Treatment of essential hypertension not controlled with monotherapy
This medicine can effectively lower blood pressure and improve blood pressure management in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or valsartan. The two components work complementarily to dilate blood vessels and regulate blood pressure. Therefore, it is used to assist in the treatment of essential hypertension and to maintain stable blood pressure.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this drug, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this drug may be considered as follows. ㆍ5/80 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this drug should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years and older: Use caution when increasing the dose.
Children: Administration of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should not be used by women who are pregnant or may become pregnant. Patients allergic to this medication's main ingredients or similar compounds and those with severe kidney or liver diseases should not take this medication. Patients with low sodium or fluid levels may experience low blood pressure, so it's important to control the condition well before taking this medication and monitor blood pressure carefully during treatment. Patients with high potassium levels should regularly check their potassium levels, as taking this medication along with other potassium-containing medications may increase potassium concentration. Patients with renal vascular issues or those who have recently undergone kidney transplantation should closely monitor renal function while taking this medication. If symptoms of angioedema such as swelling of the face, lips, or tongue occur while taking this medication, it should be discontinued immediately, and a healthcare professional should be consulted. Patients with heart failure or those recovering from myocardial infarction may experience changes in renal function or low blood pressure when taking this medication, necessitating regular check-ups. This medication may cause dizziness or fatigue while driving or operating machinery, so caution is advised. Care should be taken regarding drug interactions when taken with other antihypertensive medications, potassium-sparing diuretics, or non-steroidal anti-inflammatory drugs (NSAIDs), and blood pressure and renal function should be monitored frequently. Women who are pregnant or breastfeeding are advised against taking this medication, and those planning to become pregnant should consult a physician. The safety and efficacy in pediatric patients have not been adequately established, so use in children is not recommended. In case of overdose, low blood pressure or heart-related side effects may occur, requiring immediate medical assistance.
pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, lightheadedness, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, diaphoresis, pruritus, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, angioedema, facial swelling, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, emotional changes, tremors, sensory impairment, dysgeusia, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary dysfunction, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neural excitability, sensory impairment, Stevens-Johnson syndrome, dizziness, fatigue, systemic hypotension, reflex tachycardia, non-cardiogenic pulmonary edema
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering. The storage temperature should be maintained between 1 and 30 degrees Celsius.
Dark yellow round film-coated tablets
30 tablets - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.